Aspen Aerogels Files Supplemental Proxy Statement
Ticker: ASPN · Form: DEFA14A · Filed: May 6, 2024 · CIK: 1145986
| Field | Detail |
|---|---|
| Company | Aspen Aerogels Inc (ASPN) |
| Form Type | DEFA14A |
| Filed Date | May 6, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, supplemental-filing
Related Tickers: ASPN
TL;DR
Aspen Aerogels dropped a proxy update, check it for the annual meeting details.
AI Summary
Aspen Aerogels, Inc. filed a supplemental proxy statement on May 6, 2024, to its original proxy statement dated April 10, 2024. This filing is a definitive proxy statement related to the company's annual meeting. The company is incorporated in Delaware and headquartered in Northborough, Massachusetts.
Why It Matters
This filing provides updated information to shareholders regarding the upcoming annual meeting, which is crucial for voting on corporate matters and electing directors.
Risk Assessment
Risk Level: low — This is a routine administrative filing related to an upcoming shareholder meeting, not indicating significant new risks.
Key Players & Entities
- ASPEN AEROGELS INC (company) — Registrant
- 0001104659-24-057448 (filing_id) — Accession Number
- May 6, 2024 (date) — Filing Date
- April 10, 2024 (date) — Original Proxy Statement Date
- Northborough, Massachusetts (location) — Company Headquarters
FAQ
What is the purpose of this supplemental filing?
This filing is a supplement to the definitive proxy statement dated April 10, 2024, providing updated information for the annual meeting of stockholders.
When was the original proxy statement filed?
The original proxy statement was dated April 10, 2024.
What is the filing type?
The filing type is DEFA14A, a Definitive Proxy Statement.
Where is Aspen Aerogels, Inc. located?
Aspen Aerogels, Inc. is located at 30 Forbes Road, Building B, Northborough, Massachusetts 01532.
What is the accession number for this filing?
The accession number for this filing is 0001104659-24-057448.
Filing Stats: 445 words · 2 min read · ~1 pages · Grade level 14.9 · Accepted 2024-05-06 16:15:58
Filing Documents
- tm2413488d1_defa14a.htm (DEFA14A) — 12KB
- 0001104659-24-057448.txt ( ) — 13KB
From the Filing
UNITED SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material under § 240.14a-12 Aspen Aerogels, Inc. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check all boxes that apply): No fee required Fee paid previously with preliminary materials Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 Aspen Aerogels, Inc. 30 Forbes Road, Building B Northborough, Massachusetts 01532 SUPPLEMENT DATED MAY 6, 2024 TO PROXY STATEMENT DATED APRIL 10, 2024 FOR THE ANNUAL MEETING OF STOCKHOLDERS TO BE HELD MAY 30, 2024 On April 10, 2024, Aspen Aerogels, Inc. (the “Company”) filed a definitive proxy statement (the “Proxy Statement”) with the Securities and Exchange Commission for the Company’s Annual Meeting of Stockholders scheduled for May 30, 2024 (the “Annual Meeting”). The Company is filing this supplement to its Proxy Statement solely to correct an inadvertent error in the number of shares of common stock outstanding as of the close of business on April 3, 2024, the record date for the Annual Meeting (the “Record Date”), as previously disclosed in the Proxy Statement. The number of shares of the Company’s common stock outstanding on the Record Date reported in the Proxy Statement inadvertently included 679,796 shares of restricted stock that had previously been cancelled or forfeited. The correct number of shares outstanding on the Record Date is 76,082,328, all of which are entitled to vote at the Annual Meeting. Accordingly, the references to 76,762,124 shares of common stock on pages 4 and 10 of the Proxy Statement are hereby replaced with 76,082,328 shares of common stock. The correction of the number of shares outstanding at the close of business on the Record Date had no effect on the beneficial ownership percentages as reported in the Proxy Statement in the table under the heading “Security Ownership of Certain Beneficial Owners and Management,” except as follows: (i) all directors and current executive officers as a group held 4.2% of the outstanding common stock as of the Record Date; and (ii) entities affiliated with Koch Industries, Inc. held 24.7% of the outstanding common stock as of the Record Date. This supplement does not modify, change, amend, supplement or otherwise affect any of the other disclosures contained in the Proxy Statement.